The global endocrine testing market, valued at USD 2,536.7 million in 2024, is set for robust growth in the coming years. With a projected Compound Annual Growth Rate (CAGR) of 8.5%, the market is expected to reach an estimated valuation of USD 5,735 million by 2032.
This surge is driven by the rising prevalence of endocrine disorders, particularly diabetes, as well as the growing geriatric population. The increasing demand for accurate and early diagnosis of hormonal imbalances and disorders such as thyroid, adrenal, and pituitary conditions is also contributing to the market’s expansion. Advancements in diagnostic technologies are enabling more efficient and precise testing, further propelling the market forward.
As the global healthcare industry continues to prioritize early diagnosis and treatment of endocrine disorders, the endocrine testing market is positioned for sustained growth.
Endocrine Testing is performed through various methods, including immunoassays, chemiluminescence, and mass spectrometry, ensuring accurate and precise results. The results of these tests provide valuable information to endocrinologists and other healthcare providers, aiding in the formulation of personalized treatment plans for patients. Regular monitoring of hormone levels is also essential for patients on hormone replacement therapy or those with chronic endocrine disorders to optimize their treatment and adjust medication dosages as needed. As technology advances, Endocrine Testing continues to evolve, offering more comprehensive panels and improved sensitivity, ultimately enhancing our understanding of hormonal imbalances and their impact on overall health.
Growth Drivers:
Medical and clinical diagnostic research and development (R&D), as well as new technologies aimed at improving patient outcomes, are among the causes driving the global expansion of endocrine testing. The market has developed significantly in recent years as consumer’s desire point-of-care facilities and home-based testing kits for a wide range of health-related conditions.
As the prevalence of endocrine problems rises, as do breakthroughs in diagnostic methods, the market will expand rapidly. Furthermore, the global trend of an ageing population, combined with growing knowledge about the need of early diagnosis and prevention, is likely to drive growth in this market. The level of hormones secreted by the endocrine glands is measured in tests to diagnose illnesses such as obesity, diabetes, and thyroid disease.
The increased use of biosensors and digital test kits in pregnancy and fertility test kits is likely to fuel the expansion of the endocrine testing market.
Regional Insights:
North America, the leading market for endocrine testing, is predicted to grow at a CAGR of 47.2% during the forecast period. A large increase in R&D spending has stimulated the creation of new endocrinology lab tests, which is projected to boost the growth of the North American endocrinology lab tests market in the coming years.
Over the forecast period, the region’s endocrine testing is predicted to increase due to the adoption of new technologies and the ongoing reform of endocrine testing initiatives in a number of nations.
Europe is expected to lead the endocrine testing market in 2022 and will do so throughout the forecast period. At the moment, the European endocrine testing market accounts for 33.6% of the global endocrine testing industry.
With a revenue share of 35.6%, Asia Pacific was the largest market for endocrine testing and is likely to be the greatest in the future. China, India, Japan, and South Korea are among the countries making considerable expenditures in home-based endocrine testing kits. With a growing population, an increase in the prevalence of lifestyle-related disorders, and the development of hormonal stimulation medications, the market is expected to rise further in the next years.
Competitive Landscape:
Key Players:
- Abbott Laboratories
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- AB Sciex
- bioMerieux SA
- DiaSorin S.p.A.
- F. Hoffmann-La Roche Ltd.
- Laboratory Corporation of America Holdings
- Quest Diagnostics Incorporated
- Ortho Clinical Diagnostics
A number of strategies are being adopted by these firms in an attempt to increase their market share and gain a competitive advantage, including new product launches, facility expansions, mergers, collaborations, partnerships, and acquisitions. For instance,
- In August 2022, Mira Fertility will launch its Mira Fertility Ovum Wand which is intended to monitor the levels of the follicle-stimulating hormone (FSH) in urine. Ovulation is triggered by FSH by stimulating the growth of follicles. This product is listed as an over-the-counter tool by the US Food and Drug Administration (FDA), and it is scheduled to launch in October. It can detect lab-accurate FSH levels, helping identify and predict menopause, assess fertility, and predict ovulation.
- In May 2022, Berlin-based Inne.io startup announced an additional €9.3 million funding round led by DSM Venturing. Calm Storm Ventures and Borski Fund also participated, along with prominent angel investors Taavet Hinrikus (Wise), Fiona Pathiraja, and Rolf Schromgens (Trivago). With over 100,000 points of hormone data collected, Inne has assisted thousands of women in Switzerland, Germany, Austria, and the UK to track their progesterone levels through its mini lab and medical device registration in 2019.
Key Segments Covered in the endocrine testing Market Industry Survey
Endocrine Testing Market by Test Type:
- Estradiol (E2) Test in Endocrine Testing
- Human Chorionic Gonadotropin (hCG) Hormone Test in Endocrine Testing
- Follicle Stimulating Hormone (FSH) Test in Endocrine Testing
- Luteinizing Hormone (LH) Test in Endocrine Testing
- Progesterone Test in Endocrine Testing
- Testosterone Test in Endocrine Testing
- Thyroid Stimulating Hormone (TSH) Test in Endocrine Testing
- Dehydroepiandrosterone Sulfate (DHEAS) Test in Endocrine Testing
- Prolactin Test in Endocrine Testing
- Insulin Test in Endocrine Testing
- Cortisol Test in Endocrine Testing
- Others Endocrine Testing
Endocrine Testing Market by Technology:
- Mass Spectroscopy Endocrine Testing
- Chromatography Endocrine Testing
- Immunoassay Endocrine Testing
- Nucleic Acid Based Endocrine Testing
Endocrine Testing Market by End-user:
- Endocrine Testing at Hospitals
- Endocrine Testing at Ambulatory Care Centers
- Endocrine Testing at Commercial Laboratories
- Other Endocrine Testing
Endocrine Testing Market by Region:
- North America Endocrine Testing Market
- Latin America Endocrine Testing Market
- Europe Endocrine Testing Market
- South Asia Endocrine Testing Market
- East Asia Endocrine Testing Market
- Oceania Endocrine Testing Market
- Middle East and Africa(MEA) Endocrine Testing Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
